PMID: 28247485
Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome?
Correct Answer: yes

======================= Launch the MCC process =======================
PMID: 28247485
Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome?

----- GPT's initial response -----
GPT is reasoning the answer...


**1. Question Analysis**
- **Core Content:** The question seeks to determine whether the initial urinary albumin/creatinine ratio (ACR) measured in women with suspected preeclampsia serves as a prognostic indicator for adverse maternal and neonatal outcomes.
- **Key Information to Look For:**
  - The relationship between ACR levels and adverse outcomes.
  - Statistical significance and strength of this relationship.
  - Whether ACR remains a prognostic factor after adjusting for other variables.

**2. Evidence Evaluation**
- **Research Results and Data:**
  - The study included 717 pregnant women with suspected preeclampsia.
  - Multivariate analysis revealed that a 1-unit increase in log-transformed ACR is associated with:
    - Increased odds of adverse maternal outcomes (odds ratio 1.60, 95% CI: 1.45-1.80).
    - Increased odds of adverse neonatal outcomes (odds ratio 1.15, 95% CI: 1.02-1.29).
    - Reduced gestational age at delivery (coefficient: -0.46, 95% CI: -0.54 to -0.38).
- **Strength and Reliability:**
  - The study utilized a sizable cohort (717 women), enhancing the reliability of the findings.
  - The use of multivariable logistic regression models indicates that ACR was assessed independently of other prognostic factors.
  - Confidence intervals do not cross 1 for maternal outcomes and are narrowly above 1 for neonatal outcomes, suggesting statistical significance.
- **Relevance:**
  - The evidence directly addresses the prognostic value of ACR in the specified population (women with suspected preeclampsia).
  - The abstract clearly states that ACR is an independent prognostic factor, aligning with the research question.

**3. Conclusion**
Based on the provided abstract, the initial urinary albumin/creatinine ratio (ACR) is demonstrated to be an independent prognostic factor for both maternal and neonatal adverse outcomes in women with suspected preeclampsia. The statistical analysis supports its prognostic value even after adjusting for other factors, indicating a reliable and relevant association.

**4. Final Answer:**
**My final choice is: "yes"**
GPT selected: yes

----- Qwen's initial response -----
Qwen is reasoning the answer...


**1. Question Analysis**  
The question asks whether the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is a prognostic factor for adverse maternal and neonatal outcomes. Key elements to evaluate include:  
- Whether the study explicitly examines the first ACR's association with maternal/neonatal outcomes.  
- The statistical significance and independence of ACR as a predictor after adjusting for other factors.  

**2. Evidence Evaluation**  
The study analyzed 717 women with suspected preeclampsia, focusing on the first ACR. Multivariable logistic regression showed that a 1-unit increase in log-transformed ACR was associated with:  
- **Maternal adverse outcomes**: OR 1.60 (95% CI 1.45–1.80).  
- **Neonatal adverse outcomes**: OR 1.15 (95% CI 1.02–1.29).  
- Shorter gestational age at delivery (pooled analysis).  
The confidence intervals for maternal outcomes exclude 1, indicating statistical significance. For neonatal outcomes, the lower bound of the CI is just above 1 (1.02), suggesting marginal but still statistically significant association. The study explicitly states that ACR is an "independent prognostic factor" after adjusting for other variables.  

**3. Conclusion**  
The study provides robust statistical evidence that the first ACR is independently associated with both maternal and neonatal adverse outcomes. The multivariable analysis accounts for confounders, and the results are statistically significant. Thus, the answer is **"yes"**.  

**4. Final Answer:**  
**My final choice is: "yes"**
Qwen selected: yes

----- Deepseek's initial response -----
DeepSeek is reasoning the answer...

**1. Question Analysis**  
The question asks whether the first urinary ACR in women with suspected preeclampsia predicts adverse maternal and neonatal outcomes. Key elements to evaluate include the study's methodology, statistical associations between ACR and outcomes, and whether ACR is an independent prognostic factor after adjusting for confounders.  

**2. Evidence Evaluation**  
- The study (n=717) found that higher log-transformed ACR was independently associated with increased odds of maternal (OR 1.60, 95% CI 1.45–1.80) and neonatal (OR 1.15, 95% CI 1.02–1.29) composite adverse outcomes in multivariable analysis.  
- ACR remained significant after adjusting for other prognostic factors, confirming its independent prognostic value.  
- The results are statistically robust, with confidence intervals excluding the null value (1) for maternal outcomes and marginally for neonatal outcomes.  
- The study design (retrospective cohort) is appropriate for assessing prognosis, though limitations like potential unmeasured confounders exist.  

**3. Conclusion**  
The abstract provides strong evidence that ACR is an independent prognostic factor for adverse outcomes in this context. The multivariate analysis and statistically significant odds ratios support a "yes" answer.  

**4. Final Answer**  
**My final choice is: yes**
DeepSeek selected: yes

Initial consensus: All models selected yes